Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0000950170-24-002429

Options or other derivatives

  • General Counsel acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Winslow Garrett General Counsel 2024-01-03 Grant or award · Restricted Stock Units +100,000 100,000 D
Loading xslF345X05/ownership.xml…